Table 2.
Co-Morbidities | Overall Prevalence in Cases, n (%) | Overall Prevalence in Controls, n (%) | Odds Ratio (95% CI) * |
---|---|---|---|
Hypertension | 266 (60) | 390 (44) | 2.1 (1.6,2.7) |
Coronary artery disease | 138 (31) | 141 (16) | 2.6 (2.0,3.5) |
Peripheral vascular disease | 85 (19) | 38 (4) | 7.9 (4.7,13.2) |
Cerebrovascular disease | 91 (20) | 70 (8) | 3.2 (2.3,4.6) |
Hypotensive episode past month | 82 (18) | 5 (1) | 33.0 (13.3,80.9) |
Congestive heart failure | 70 (16) | 43 (5) | 4.1 (2.6,6.3) |
Hyperlipidemia | 146 (33) | 358 (40) | 0.7 (0.5,0.9) |
Current smoking | 79 (18) | 94 (11) | 1.9 (1.3,2.7) |
Ever smoking (current plus former) | 240 (55) | 412 (47) | 1.4 (1.1,1.8) |
Diabetes mellitus | 77 (17) | 90 (10) | 2.0 (1.4,2.8) |
Irritable bowel syndrome | 33 (7) | 49 (6) | 1.4 (0.9,2.3) |
History of thromboembolism | 29 (6) | 31 (3) | 1.9 (1.2,3.3) |
Aortic aneurysm or coronary bypass surgery | 33 (7) | 29 (3) | 2.5 (1.5,4.2) |
Collagen vascular disease | 12 (3) | 3 (0.3) | 8.0 (2.2,28.3) |
Chronic obstructive pulmonary disease | 67 (15) | 30 (5) | 3.1 (1.8,5.2) |
Obesity (BMI >30) | 89 (26) | 242 (28) | 0.9 (0.6,1.3) |
Medication Use (Past 30 Days) | |||
Diuretics | 160 (36) | 235 (26) | 1.6 (1.2,2.1) |
Digoxin | 40 (9) | 26 (3) | 3.6 (2.1,6.2) |
NSAIDs | 68 (15) | 154 (17) | 0.9 (0.6,1.2) |
Estrogen replacement † | 46 (15) | 90 (15) | 1.0 (0.7,1.5) |
Psychotropic medications | 10 (2) | 6 (1) | 3.7 (1.3,11.0) |
Oral contraceptives † | 9 (3) | 25 (4) | 0.7 (0.3,1.5) |
Pseudoephedrine | 4 (1) | 7 (1) | 1.1 (0.3,3.9) |
Migraine medications | 7 (2) | 6 (0.7) | 2.3 (0.8,6.9) |
Gold | 0 | 0 | - |
Odds ratio and 95% confidence interval using conditional logistic regression (which accounts for the matching) including only birth date as a covariate.
Among the 297 female ischemic colitis patients and their corresponding controls (6 males did receive estrogen therapy[2 ischemic colitis patients and 4 controls] but are not included in the analysis).